Search
Skip to Search Results- 2Gainer, Anita Lillian, 1956-
- 1Abdel-Monem, Hanan Ahmed Fahmy.
- 1Acker, Jason Paul
- 1Acker, Jason Paul.
- 1Alladina, Salim Jafferali
- 1Almizraq, Ruqayyah J.
- 3Apoptosis.
- 3Cell adhesion molecules.
- 3Ligands (Biochemistry)
- 2Alkaline phosphatase.
- 2Antigens
- 2Breast--Cancer
-
Evaluating the Persistence of Dissolved Heteroatomic Organic Chemicals in Oil Sands Process-Affected Water by Non-Targeted Analysis
DownloadSpring 2021
Over 1 billion m3 of wastewater in tailings ponds currently awaits remediation as a result of the extraction of bitumen – the Canadian oil sands ore. Relative to the Athabasca River and regional tributaries, oil sands process-affected water (OSPW) has increased levels of salts, metals and a...
-
Exploring the Interplay between Donor Sex, CD71+ RBCs, Erythrophagocytosis and Hospital-onset Sepsis
DownloadSpring 2024
Transfusion of red cell concentrates (RCCs) is common for treating anemia in Intensive care unit (ICU) patients, but it may result in adverse outcomes like sepsis, potentially due to donor sex-related immune responses. CD71+ RBCs, which are immature, may influence erythrophagocytosis, where the...
-
Identification and Validation of a Common Molecular Signature of Progressive Fibrosis in Human Livers
DownloadSpring 2020
Over 25% of the world population suffer from chronic liver disease. Most common causes are long-term viral infections, alcohol abuse, and non-alcoholic fatty liver disease (NAFLD) associated with obesity, diabetes or hyperlipidemia. Chronic liver disease due to any cause is characterized by...
-
Increased estrogen receptor expression leads to a novel DNA binding signature which differentiates luminal A and luminal B breast cancers
DownloadFall 2018
Eighty percent of all breast cancers are estrogen receptor positive (ER+) and molecular profiling has identified two ER+ subtypes: luminal A and luminal B. The accurate diagnosis of these luminal subtypes is one of the greatest clinical challenges with current gene assays obtaining only 75%...
-
Spring 2020
The early detection of disease is beneficial for improved patient prognoses. One major challenge in early disease detection is the small, undetectable amounts of biomarkers. Detection strategies that confer amplification of the biomarker itself or of the detection signal are therefore desirable....